Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Atorvastatin vs Rosuvastatin in HIV-infected Adults
NCT03037372Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Jun 2017
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of atorvastatin, rosuvastatin in human immunodeficiency virus infection (HIV), sponsored by Makerere University. Status: unknown.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03037372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037372.